Powles T - Search Results

1

The application of the National Institute of Clinical Excellence guidelines for treatment of metastatic renal cell carcinoma in the United Kingdom: friend or foe?

Powles T, Jones R, Chowdhury S, Shamash J, Mantle M, Lim L, Hutson T. Powles T, et al. BJU Int. 2010 Aug;106(4):453-7. doi: 10.1111/j.1464-410X.2010.09466.x. Epub 2010 Jun 22. BJU Int. 2010. PMID: 20576026 No abstract available.

2

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.

Powles T, Shamash J, Berney D, Oliver RT. Powles T, et al. Br J Cancer. 2003 Sep 15;89(6):1140-1; author reply 1141-2. doi: 10.1038/sj.bjc.6601176. Br J Cancer. 2003. PMID: 12966438 Free PMC article. No abstract available.

3

Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity.

Liu WM, Powles T, Shamash J, Propper D, Oliver T, Joel S. Liu WM, et al. Among authors: powles t. Oncogene. 2004 Jan 29;23(4):981-90. doi: 10.1038/sj.onc.1207294. Oncogene. 2004. PMID: 14647427

4

Erythropoietin to treat anaemia in patients with head and neck cancer.

Powles T, Shamash J, Liu W. Powles T, et al. Lancet. 2004 Jan 3;363(9402):82. doi: 10.1016/S0140-6736(03)15189-6. Lancet. 2004. PMID: 14724015 No abstract available.

5

Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway.

Powles T, te Poele R, Shamash J, Chaplin T, Propper D, Joel S, Oliver T, Liu WM. Powles T, et al. Blood. 2005 Feb 1;105(3):1214-21. doi: 10.1182/blood-2004-03-1182. Epub 2004 Sep 28. Blood. 2005. PMID: 15454482 Free article.

6

Prognostic factors in cytokine-refractory renal cell carcinoma treated with irinotecan, Cisplatin, and mitomycin chemotherapy.

Shamash J, Powles T, Wilson P, Ansell W, Oliver T. Shamash J, et al. Among authors: powles t. J Clin Oncol. 2005 Feb 20;23(6):1323-5. doi: 10.1200/JCO.2005.05.107. J Clin Oncol. 2005. PMID: 15718335 No abstract available.

7

The changing presentation of germ cell tumours of the testis between 1983 and 2002.

Powles TB, Bhardwa J, Shamash J, Mandalia S, Oliver T. Powles TB, et al. BJU Int. 2005 Jun;95(9):1197-200. doi: 10.1111/j.1464-410X.2005.05504.x. BJU Int. 2005. PMID: 15892800

8

Assessing the size and stage of testicular germ cell tumours: 1984-2003.

Bhardwa JM, Powles T, Berney D, Baithun S, Nargund VH, Oliver RT. Bhardwa JM, et al. Among authors: powles t. BJU Int. 2005 Oct;96(6):819-21. doi: 10.1111/j.1464-410X.2005.05748.x. BJU Int. 2005. PMID: 16153209

9

A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours.

Shamash J, Powles T, Mutsvangwa K, Wilson P, Ansell W, Walsh E, Berney D, Stebbing J, Oliver T. Shamash J, et al. Among authors: powles t. Ann Oncol. 2007 May;18(5):925-30. doi: 10.1093/annonc/mdm002. Epub 2007 Mar 12. Ann Oncol. 2007. PMID: 17355956 Free article. Clinical Trial.

10

GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.

Shamash J, Powles T, Ansell W, Berney D, Stebbing J, Mutsvangwa K, Wilson P, Asterling S, Liu S, Wyatt P, Joel SP, Oliver RT. Shamash J, et al. Among authors: powles t. Br J Cancer. 2007 Aug 6;97(3):308-14. doi: 10.1038/sj.bjc.6603865. Epub 2007 Jul 3. Br J Cancer. 2007. PMID: 17609665 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

839 results

Search Page

Filters